Specialties & Topics
- Arthritis/Rheumatic Disease
- Breast Cancer
- GERD/Peptic Ulcers
September 12th, 2009
Podcast 56: A conversation with two JAMA staffers on their research into “ghost” authorship and “honorary” authorship in the principal medical journals.
(2 votes, average: 4.50 out of 5)
We’ve seen research into this area before — 18 months ago, in fact. (We interviewed Joseph Ross back then in Podcast #2.) This time we interview Joseph Wislar, a survey-research specialist at JAMA, and Annette Flanagin, its managing deputy editor. They’ve just presented the abstracted results of a survey on ghost and honorary authorship that encompasses hundreds of articles from the principal medical journals.
If you would like to comment, give us a call and leave a message at 1-617-440-4374 or drop me a note at firstname.lastname@example.org.
This week’s links:
- Barack Obama speech transcript
- H1N1 Update: Early Results on Vaccine Indicate One Dose May Be Sufficient for Most Groups
- FDA Advisers: HPV Vaccine Should Be Approved for Use in Boys, Young Men
- New York Times story on “ghostwriting” in the principal medical journals
- Link to last year’s interview with Joseph Ross
- Physician’s First Watch coverage
About the Podcast
To have your comment included in a future podcast, call 617-440-4374. Please leave your name, number, and the podcast ID number.
- Podcast 126: Placebos and Medical ‘Meaning’ (4)
- Podcast 199: Rethinking what medical journals do (3)
- Podcast 149: High levels of white rice consumption seem linked to higher risks for type 2 diabetes (3)
- Podcast 111: A look back on the year’s most clinically important developments. (3)
- Podcast 186: Stop supplementing calcium! (3)
- Risk for 13 Cancers Is Lower When Leisure-Time Physical Activity Is Higher
- Half of Antidepressants Prescribed in Quebec Primary Care Are for Nondepressive Indications (FREE)
- Endocrine Treatment Helps Patients with Rare Telomere Diseases
- Critical Illness Has Lasting Effects on Patients and Caregivers
- Vilanterol and Fluticasone for COPD: No Mortality Benefit
Physician's First WatchToday's breaking medical news
- 2009 H1N1 acute coronary syndromes antidepressants aspirin asthma breast cancer cancer risk cardiovascular disease Cardiovascular risk clopidogrel COPD coronary heart disease dabigatran dementia depression diabetes Diabetes type 2 diet Elderly Emergency medicine falls FDA glucose guidelines H1N1 Heart failure hemoglobin A1c hypertension influenza pain Patient care patients PPI pregnancy Prostate cancer proton pump inhibitors PSA risk rosiglitazone screening smoking stents stroke vaccination warfarin